Thrivent Financial for Lutherans
TMO icon

Thrivent Financial for Lutherans’s Thermo Fisher Scientific TMO Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$33.3M Sell
82,132
-2,117
-3% -$858K 0.07% 297
2025
Q1
$42M Buy
84,249
+3,973
+5% +$1.98M 0.09% 275
2024
Q4
$41.8M Sell
80,276
-2,629
-3% -$1.37M 0.08% 312
2024
Q3
$51.3M Sell
82,905
-36,714
-31% -$22.7M 0.1% 268
2024
Q2
$66.1M Buy
119,619
+6,185
+5% +$3.42M 0.13% 201
2024
Q1
$65.9M Buy
113,434
+17,614
+18% +$10.2M 0.13% 206
2023
Q4
$50.9M Buy
95,820
+355
+0.4% +$188K 0.11% 249
2023
Q3
$48.3M Buy
95,465
+1,508
+2% +$763K 0.11% 239
2023
Q2
$49M Buy
93,957
+68,169
+264% +$35.5M 0.11% 239
2023
Q1
$14.8M Sell
25,788
-4,453
-15% -$2.56M 0.04% 498
2022
Q4
$16.7M Sell
30,241
-7,375
-20% -$4.07M 0.04% 463
2022
Q3
$19.2M Sell
37,616
-225,762
-86% -$115M 0.05% 402
2022
Q2
$143M Sell
263,378
-6,502
-2% -$3.53M 0.38% 45
2022
Q1
$159M Buy
269,880
+21,723
+9% +$12.8M 0.31% 73
2021
Q4
$164M Sell
248,157
-68,909
-22% -$45.5M 0.32% 71
2021
Q3
$181M Sell
317,066
-11,913
-4% -$6.81M 0.37% 53
2021
Q2
$166M Sell
328,979
-14,072
-4% -$7.1M 0.34% 55
2021
Q1
$157M Buy
343,051
+36,755
+12% +$16.8M 0.34% 51
2020
Q4
$143M Sell
306,296
-32,169
-10% -$15M 0.33% 56
2020
Q3
$149M Sell
338,465
-48,872
-13% -$21.6M 0.4% 43
2020
Q2
$140M Sell
387,337
-15,057
-4% -$5.45M 0.42% 40
2020
Q1
$114M Buy
402,394
+13,658
+4% +$3.87M 0.41% 43
2019
Q4
$126M Sell
388,736
-40,136
-9% -$13M 0.36% 50
2019
Q3
$125M Sell
428,872
-119,668
-22% -$34.9M 0.39% 50
2019
Q2
$161M Buy
548,540
+53,717
+11% +$15.8M 0.49% 34
2019
Q1
$135M Buy
494,823
+67,566
+16% +$18.5M 0.43% 49
2018
Q4
$95.6M Buy
427,257
+20,985
+5% +$4.7M 0.35% 59
2018
Q3
$99.2M Buy
406,272
+47,940
+13% +$11.7M 0.31% 67
2018
Q2
$74.2M Buy
358,332
+196,272
+121% +$40.7M 0.24% 90
2018
Q1
$33.5M Sell
162,060
-20,926
-11% -$4.32M 0.11% 161
2017
Q4
$34.7M Buy
182,986
+4,983
+3% +$946K 0.12% 166
2017
Q3
$33.7M Sell
178,003
-11,660
-6% -$2.21M 0.12% 171
2017
Q2
$33.1M Buy
189,663
+175,333
+1,224% +$30.6M 0.14% 161
2017
Q1
$2.2M Buy
14,330
+570
+4% +$87.5K 0.01% 811
2016
Q4
$1.94M Buy
13,760
+880
+7% +$124K 0.01% 872
2016
Q3
$2.05M Buy
12,880
+750
+6% +$119K 0.01% 860
2016
Q2
$1.79M Buy
12,130
+480
+4% +$70.9K 0.01% 909
2016
Q1
$1.65M Buy
11,650
+510
+5% +$72.2K 0.01% 926
2015
Q4
$1.58M Buy
11,140
+290
+3% +$41.1K 0.01% 919
2015
Q3
$1.33M Sell
10,850
-10,600
-49% -$1.3M 0.01% 899
2015
Q2
$2.78M Buy
21,450
+500
+2% +$64.9K 0.02% 596
2015
Q1
$2.81M Buy
20,950
+300
+1% +$40.3K 0.02% 614
2014
Q4
$2.59M Sell
20,650
-750
-4% -$94K 0.01% 633
2014
Q3
$2.6M Buy
21,400
+250
+1% +$30.4K 0.02% 621
2014
Q2
$2.5M Buy
21,150
+11,950
+130% +$1.41M 0.01% 653
2014
Q1
$1.11M Buy
9,200
+800
+10% +$96.2K 0.01% 701
2013
Q4
$935K Buy
8,400
+100
+1% +$11.1K 0.01% 779
2013
Q3
$765K Sell
8,300
-4,000
-33% -$369K ﹤0.01% 778
2013
Q2
$1.04K Buy
+12,300
New +$1.04K 0.01% 705